Weighted Average Number of Shares Outstanding, Basic of Y-mAbs Therapeutics, Inc. from 31 Dec 2019 to 30 Jun 2025

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Y-mAbs Therapeutics, Inc. quarterly and annual Weighted Average Number of Shares Outstanding, Basic in shares history and change rate from 31 Dec 2019 to 30 Jun 2025.
  • Y-mAbs Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending 30 Jun 2025 was 45,318,028, a 2.9% increase year-over-year.
  • Y-mAbs Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2024 was 44,328,962, a 1.6% increase from 2023.
  • Y-mAbs Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 43,645,388, a 0.13% decline from 2022.
  • Y-mAbs Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 43,703,663, a 1.2% increase from 2021.
Source SEC data
View on sec.gov
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Change (%)
Weighted Average Number of Shares Outstanding, Basic, Annual (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Annual Change (%)

Y-mAbs Therapeutics, Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic (shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q2 2025 45,318,028 +1,295,672 +2.9% 01 Apr 2025 30 Jun 2025 10-Q 08 Aug 2025 2025 Q2
Q1 2025 45,104,476 +1,325,020 +3% 01 Jan 2025 31 Mar 2025 10-Q 13 May 2025 2025 Q1
Q4 2024 44,328,962 +683,574 +1.6% 01 Oct 2024 31 Dec 2024 10-K 04 Mar 2025 2024 FY
Q3 2024 44,626,943 +1,006,411 +2.3% 01 Jul 2024 30 Sep 2024 10-Q 08 Nov 2024 2024 Q3
Q2 2024 44,022,356 +359,244 +0.82% 01 Apr 2024 30 Jun 2024 10-Q 08 Aug 2025 2025 Q2
Q1 2024 43,779,456 +107,867 +0.25% 01 Jan 2024 31 Mar 2024 10-Q 13 May 2025 2025 Q1
Q4 2023 43,645,388 -58,275 -0.13% 01 Oct 2023 31 Dec 2023 10-K 04 Mar 2025 2024 FY
Q3 2023 43,620,532 -97,819 -0.22% 01 Jul 2023 30 Sep 2023 10-Q 08 Nov 2024 2024 Q3
Q2 2023 43,663,112 -55,636 -0.13% 01 Apr 2023 30 Jun 2023 10-Q 12 Aug 2024 2024 Q2
Q1 2023 43,671,589 -37,649 -0.09% 01 Jan 2023 31 Mar 2023 10-Q 07 May 2024 2024 Q1
Q4 2022 43,703,663 +521,855 +1.2% 01 Oct 2022 31 Dec 2022 10-K 29 Feb 2024 2023 FY
Q3 2022 43,718,351 +120,001 +0.28% 01 Jul 2022 30 Sep 2022 10-Q 13 Nov 2023 2023 Q3
Q2 2022 43,718,748 +149,266 +0.34% 01 Apr 2022 30 Jun 2022 10-Q 10 Aug 2023 2023 Q2
Q1 2022 43,709,238 +1,838,479 +4.4% 01 Jan 2022 31 Mar 2022 10-Q 08 May 2023 2023 Q1
Q4 2021 43,181,808 +3,063,271 +7.6% 01 Oct 2021 31 Dec 2021 10-K 30 Mar 2023 2022 FY
Q3 2021 43,598,350 +3,411,177 +8.5% 01 Jul 2021 30 Sep 2021 10-Q 07 Nov 2022 2022 Q3
Q2 2021 43,569,482 +3,597,308 +9% 01 Apr 2021 30 Jun 2021 10-Q 08 Aug 2022 2021 Q3
Q1 2021 41,870,759 +2,117,176 +5.3% 01 Jan 2021 31 Mar 2021 10-Q 09 May 2022 2022 Q1
Q4 2020 40,118,537 01 Oct 2020 31 Dec 2020 10-K 01 Mar 2022 2021 FY
Q3 2020 40,187,173 01 Jul 2020 30 Sep 2020 10-Q 04 Nov 2021 2021 Q3
Q2 2020 39,972,174 01 Apr 2020 30 Jun 2020 10-Q 09 Aug 2021 2021 Q2
Q1 2020 39,753,583 01 Jan 2020 31 Mar 2020 10-Q 06 May 2021 2021 Q1

Y-mAbs Therapeutics, Inc. Annual Weighted Average Number of Shares Outstanding, Basic (shares)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 44,328,962 +683,574 +1.6% 01 Jan 2024 31 Dec 2024 10-K 04 Mar 2025 2024 FY
2023 43,645,388 -58,275 -0.13% 01 Jan 2023 31 Dec 2023 10-K 04 Mar 2025 2024 FY
2022 43,703,663 +521,855 +1.2% 01 Jan 2022 31 Dec 2022 10-K 29 Feb 2024 2023 FY
2021 43,181,808 +3,063,271 +7.6% 01 Jan 2021 31 Dec 2021 10-K 30 Mar 2023 2022 FY
2020 40,118,537 +4,935,049 +14% 01 Jan 2020 31 Dec 2020 10-K 01 Mar 2022 2021 FY
2019 35,183,488 01 Jan 2019 31 Dec 2019 10-K 01 Mar 2022 2021 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.